Cargando…
A clinical study of the correlation between metabolic-associated fatty liver disease and coronary plaque pattern
Nonalcoholic fatty liver disease (NAFLD) is the hepatic manifestation of metabolic syndrome (MetS) and has been correlated with coronary atherosclerosis (CAS). Since NAFLD was renamed metabolic-associated fatty liver disease(MAFLD) in 2020, no studies have evaluated the correlation between MAFLD and...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10160090/ https://www.ncbi.nlm.nih.gov/pubmed/37142746 http://dx.doi.org/10.1038/s41598-023-34462-8 |
_version_ | 1785037212160622592 |
---|---|
author | Zhang, Zhijiao Zheng, Mengyao Lei, Hongtao Jiang, Zimeng Chen, Yuhang He, Haiyu Zhao, Gongfang Huang, Hua |
author_facet | Zhang, Zhijiao Zheng, Mengyao Lei, Hongtao Jiang, Zimeng Chen, Yuhang He, Haiyu Zhao, Gongfang Huang, Hua |
author_sort | Zhang, Zhijiao |
collection | PubMed |
description | Nonalcoholic fatty liver disease (NAFLD) is the hepatic manifestation of metabolic syndrome (MetS) and has been correlated with coronary atherosclerosis (CAS). Since NAFLD was renamed metabolic-associated fatty liver disease(MAFLD) in 2020, no studies have evaluated the correlation between MAFLD and CAS. The aim of this study was to evaluate the relationship between MAFLD and CAS. A total of 1330 patients underwent continuous coronary computed tomography angiography (CCTA) and abdominal ultrasound as part of a routine physical examination. Ultrasonography was used to assess fatty liver, and CCTA was used to assess coronary artery plaques, degree of stenosis, and diseased blood vessels. Univariate and multivariate logistic regression analyses were performed with plaque type and degree of stenosis as dependent variables and MAFLD and traditional cardiovascular risk factors as independent variables to analyze the correlation between MAFLD and CAS. Among the 1164 patients, 680 (58.4%) were diagnosed with MAFLD through a combination of ultrasound and auxiliary examinations. Compared with the non-MAFLD group, the MAFLD group had more cardiovascular risk factors,and the MAFLD group had more likely to have coronary atherosclerosis, coronary stenosis and multiple coronary artery stenosis.In the univariate logistic regression, MAFLD was significantly correlated with overall plaque, calcified plaques, noncalcified plaques, mixed plaques,and significant stenosis in the coronary arteries.(p < 0.05). After adjusting for cardiovascular risk factors , MAFLD was correlated with noncalcified plaques (1.67; 95% confidence interval (CI) 1.15–2.43; p = 0.007) and mixed plaques (1.54; 95% CI 1.10–2.16; p = 0.011). In this study, MAFLD group had more cardiovascular risk factors, MAFLD was correlated with coronary atherosclerosis,and significant stenosis.Further study found independent associations between MAFLD and noncalcified plaques and mixed plaques, which suggest a clinically relevant link between MAFLD and coronary atherosclerosis. |
format | Online Article Text |
id | pubmed-10160090 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-101600902023-05-06 A clinical study of the correlation between metabolic-associated fatty liver disease and coronary plaque pattern Zhang, Zhijiao Zheng, Mengyao Lei, Hongtao Jiang, Zimeng Chen, Yuhang He, Haiyu Zhao, Gongfang Huang, Hua Sci Rep Article Nonalcoholic fatty liver disease (NAFLD) is the hepatic manifestation of metabolic syndrome (MetS) and has been correlated with coronary atherosclerosis (CAS). Since NAFLD was renamed metabolic-associated fatty liver disease(MAFLD) in 2020, no studies have evaluated the correlation between MAFLD and CAS. The aim of this study was to evaluate the relationship between MAFLD and CAS. A total of 1330 patients underwent continuous coronary computed tomography angiography (CCTA) and abdominal ultrasound as part of a routine physical examination. Ultrasonography was used to assess fatty liver, and CCTA was used to assess coronary artery plaques, degree of stenosis, and diseased blood vessels. Univariate and multivariate logistic regression analyses were performed with plaque type and degree of stenosis as dependent variables and MAFLD and traditional cardiovascular risk factors as independent variables to analyze the correlation between MAFLD and CAS. Among the 1164 patients, 680 (58.4%) were diagnosed with MAFLD through a combination of ultrasound and auxiliary examinations. Compared with the non-MAFLD group, the MAFLD group had more cardiovascular risk factors,and the MAFLD group had more likely to have coronary atherosclerosis, coronary stenosis and multiple coronary artery stenosis.In the univariate logistic regression, MAFLD was significantly correlated with overall plaque, calcified plaques, noncalcified plaques, mixed plaques,and significant stenosis in the coronary arteries.(p < 0.05). After adjusting for cardiovascular risk factors , MAFLD was correlated with noncalcified plaques (1.67; 95% confidence interval (CI) 1.15–2.43; p = 0.007) and mixed plaques (1.54; 95% CI 1.10–2.16; p = 0.011). In this study, MAFLD group had more cardiovascular risk factors, MAFLD was correlated with coronary atherosclerosis,and significant stenosis.Further study found independent associations between MAFLD and noncalcified plaques and mixed plaques, which suggest a clinically relevant link between MAFLD and coronary atherosclerosis. Nature Publishing Group UK 2023-05-04 /pmc/articles/PMC10160090/ /pubmed/37142746 http://dx.doi.org/10.1038/s41598-023-34462-8 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Zhang, Zhijiao Zheng, Mengyao Lei, Hongtao Jiang, Zimeng Chen, Yuhang He, Haiyu Zhao, Gongfang Huang, Hua A clinical study of the correlation between metabolic-associated fatty liver disease and coronary plaque pattern |
title | A clinical study of the correlation between metabolic-associated fatty liver disease and coronary plaque pattern |
title_full | A clinical study of the correlation between metabolic-associated fatty liver disease and coronary plaque pattern |
title_fullStr | A clinical study of the correlation between metabolic-associated fatty liver disease and coronary plaque pattern |
title_full_unstemmed | A clinical study of the correlation between metabolic-associated fatty liver disease and coronary plaque pattern |
title_short | A clinical study of the correlation between metabolic-associated fatty liver disease and coronary plaque pattern |
title_sort | clinical study of the correlation between metabolic-associated fatty liver disease and coronary plaque pattern |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10160090/ https://www.ncbi.nlm.nih.gov/pubmed/37142746 http://dx.doi.org/10.1038/s41598-023-34462-8 |
work_keys_str_mv | AT zhangzhijiao aclinicalstudyofthecorrelationbetweenmetabolicassociatedfattyliverdiseaseandcoronaryplaquepattern AT zhengmengyao aclinicalstudyofthecorrelationbetweenmetabolicassociatedfattyliverdiseaseandcoronaryplaquepattern AT leihongtao aclinicalstudyofthecorrelationbetweenmetabolicassociatedfattyliverdiseaseandcoronaryplaquepattern AT jiangzimeng aclinicalstudyofthecorrelationbetweenmetabolicassociatedfattyliverdiseaseandcoronaryplaquepattern AT chenyuhang aclinicalstudyofthecorrelationbetweenmetabolicassociatedfattyliverdiseaseandcoronaryplaquepattern AT hehaiyu aclinicalstudyofthecorrelationbetweenmetabolicassociatedfattyliverdiseaseandcoronaryplaquepattern AT zhaogongfang aclinicalstudyofthecorrelationbetweenmetabolicassociatedfattyliverdiseaseandcoronaryplaquepattern AT huanghua aclinicalstudyofthecorrelationbetweenmetabolicassociatedfattyliverdiseaseandcoronaryplaquepattern AT zhangzhijiao clinicalstudyofthecorrelationbetweenmetabolicassociatedfattyliverdiseaseandcoronaryplaquepattern AT zhengmengyao clinicalstudyofthecorrelationbetweenmetabolicassociatedfattyliverdiseaseandcoronaryplaquepattern AT leihongtao clinicalstudyofthecorrelationbetweenmetabolicassociatedfattyliverdiseaseandcoronaryplaquepattern AT jiangzimeng clinicalstudyofthecorrelationbetweenmetabolicassociatedfattyliverdiseaseandcoronaryplaquepattern AT chenyuhang clinicalstudyofthecorrelationbetweenmetabolicassociatedfattyliverdiseaseandcoronaryplaquepattern AT hehaiyu clinicalstudyofthecorrelationbetweenmetabolicassociatedfattyliverdiseaseandcoronaryplaquepattern AT zhaogongfang clinicalstudyofthecorrelationbetweenmetabolicassociatedfattyliverdiseaseandcoronaryplaquepattern AT huanghua clinicalstudyofthecorrelationbetweenmetabolicassociatedfattyliverdiseaseandcoronaryplaquepattern |